Abstract
There are no data in the literature about the efficacy of influenza vaccination in lung cancer patients. Paired sera were available from 59 patients who received Fluvirin (Evans Medical). Of 41 patients susceptible to one or more influenza strains, 78% responded fully to vaccination. This response rate is comparable to that obtained from healthy volunteers.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Department of Health (1996) Immunisation against Infectious Disease, Salisbury DM, Begg NT, (eds) pp 113–120. HMSO: London
Editorial (1997) Uptake of vaccine in high risk patients. Commun Dis Rep Weekly 7: 407
Lorio, A. M., Rivosecchi, P., Zei, P., Neri, M. & Merlett, L. (1989) Immune response to trivalent inactivated influenza vaccine in young and elderly subjects. Vaccine 7: 303–306.
Ortbals, D. W., Liebhaber, H., Presant, C. A., van Amburg, A. L. & Lee, J. Y. (1977) Influenza immunisation of adult patients with malignant diseases. Ann Intern Med 87: 552–557.
Shildt, R. A., Luedke, D. W., Kasai, G., El-Beheri, S. & Laham, M. N. (1979) Antibody response to influenza immunisation in adult patients with malignant disease. Cancer 44: 1629–1635.
Watkins, J. (1997) Effectiveness of influenza vaccination policy at targeting patients at high risk of complications during winter 1994–95: Cross Sectional Survey. BMJ 315: 1069–1070.
Yousuf, H. M., Englund, J., Couch, R., Rolston, K., Luna, M. & Goodrich, J. (1997) Influenza among hospitalised adults with leukaemia. Clinical Infectious Diseases 24: 1095–1099.
Author information
Authors and Affiliations
Additional information
Fluvirin supplied by Evans Medical
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Anderson, H., Petrie, K., Berrisford, C. et al. Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer 80, 219–220 (1999). https://doi.org/10.1038/sj.bjc.6690342
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690342
Keywords
This article is cited by
-
Impfen bei Immundefizienz
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2020)
-
Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study
British Journal of Cancer (2011)
-
Serological immune responses to influenza vaccine in patients with colorectal cancer
Cancer Chemotherapy and Pharmacology (2011)
-
Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice
Oncogene (2004)
